Details for: CL0000931

Cell ID: CL0000931

Cell Name: activated type II NK T cell

Description: A type II NK T cell that has been recently activated, secretes interferon-gamma and interleukin-4, and has the phenotype CD69-positive and downregulated NK markers.

Synonyms: activated type II NK T lymphocyte, activated type II NK T-cell, activated type II NK T-lymphocyte, activated type II NKT cell

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for activated type II NK T cell within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for activated type II NK T cell. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for activated type II NK T cell. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for activated type II NK T cell. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  activated type II NK T cell (CL0000931)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [activated type II NK T cell](/details-cell/CL0000931) is a specialized lymphocyte subtype that embodies features of both innate and adaptive immunity. As indicated by its formal description, it is a recently activated cell capable of secreting key cytokines. The gene significance profile suggests its identity is profoundly defined by a state of intense metabolic activity, highlighted by the exceptional specificity of mitochondrial genes such as [COX1](/details-gene/4512). This high-energy state supports a potent cytotoxic effector program, underscored by the co-expression of genes involved in antigen presentation and cytolysis, including [B2M](/details-gene/567) and [HLA E](/details-gene/3133). **Overall**, the data portrays an effector cell that is metabolically primed for immediate and sustained immune function. ## Key Characteristics and Function Analysis of the top marker genes, based on their expression specificity (`csi_z`), reveals several core functional clusters that define the [activated type II NK T cell](/details-cell/CL0000931). * **Intense Metabolic Activity:** A dominant feature of this cell is the highly specific expression of numerous genes integral to the mitochondrial respiratory chain and oxidative phosphorylation. This includes multiple subunits of cytochrome c oxidase ([COX1](/details-gene/4512), [COX2](/details-gene/4513)) and NADH dehydrogenase ([ND5](/details-gene/4540), [ND3](/details-gene/4537)), as well as cytochrome b ([CYTB](/details-gene/4519)). This strong metabolic signature is consistent with the high energetic demands required to fuel effector functions such as cytokine production and cytotoxicity following activation. * **Cytotoxicity and Immune Recognition:** The cell is equipped for direct target cell elimination and immune communication. The high significance of [PRF1](/details-gene/5551) (Perforin) provides direct evidence for its cytotoxic potential. Furthermore, the prominence of [B2M](/details-gene/567) (Beta-2-microglobulin) and the non-classical MHC class I molecule [HLA E](/details-gene/3133) suggests a key role in antigen presentation and immune recognition. [HLA E](/details-gene/3133) is particularly noteworthy as it can interact with inhibitory (NKG2A) and activating (NKG2C) receptors on NK cells and some T cells, positioning this cell type as a regulator of other lymphocyte populations. * **Dynamic Cellular Regulation and Plasticity:** A significant number of top markers are involved in regulating fundamental cellular processes, indicative of a dynamic, activated state. This includes genes controlling mRNA stability ([ZFP36](/details-gene/7538)), RNA splicing and processing ([DDX5](/details-gene/1655), [HNRNPA2B1](/details-gene/6934)), protein turnover via the ubiquitin system ([UBC](/details-gene/7316), [UBB](/details-gene/7314)), and cytoskeletal rearrangement ([CFL1](/details-gene/1072), [MYL12A](/details-gene/10627)). The high specificity of the anti-proliferative gene [BTG1](/details-gene/694) may indicate that upon activation, these cells prioritize effector function over clonal expansion. * **Cellular Lineage and Identity:** The anti-marker profile helps refine the cell's identity. The low significance of the neutrophil chemokine receptor [CXCR2](/details-gene/3579) clearly distinguishes it from the myeloid lineage. Intriguingly, [IFNG](/details-gene/3458) (Interferon-gamma), a canonical cytokine product mentioned in the cell's description, shows a very low specificity score. This suggests that while [activated type II NK T cells](/details-cell/CL0000931) do produce IFN-gamma, its expression is not a unique or defining feature compared to other activated immune cells, which likely express it at similar or higher levels. ## Clinical Significance and Contextual Roles The **Overall** gene signature of the [activated type II NK T cell](/details-cell/CL0000931) points to its potential significance in both protective immunity and immunopathology. The potent cytotoxic machinery, marked by [PRF1](/details-gene/5551), and its unique recognition capabilities via molecules like [HLA E](/details-gene/3133), suggest a critical role in immune surveillance against virally infected cells and malignancies. The high metabolic state implies that these cells can sustain their effector functions over time, which is crucial for clearing persistent infections or controlling tumor growth. The high specificity of regulatory genes like [ZFP36](/details-gene/7538) is also clinically relevant. [ZFP36](/details-gene/7538) is an RNA-binding protein that promotes the degradation of mRNAs for inflammatory cytokines, including TNF-alpha. Its prominence as a marker suggests that the effector response of these cells is tightly regulated at the post-transcriptional level to prevent excessive inflammation and tissue damage, a common risk associated with potent cytotoxic lymphocytes. Dysregulation of this control mechanism could contribute to autoimmune or inflammatory conditions. The specific expression of replication-independent histones [H3 3A](/details-gene/3020) and [H3 3B](/details-gene/3021) suggests that the cell maintains a dynamic and open chromatin state to support its transcriptional program, a feature that could be exploited for therapeutic modulation. ## Potential Mechanisms and Research Directions 1. **Hypothesis: The identity of an activated Type II NK T cell is primarily defined by its metabolic state rather than its immunologic effectors.** The data strongly suggests that the most unique and defining feature of this cell is its profound commitment to oxidative phosphorylation, as evidenced by the dominance of mitochondrial genes in its specificity profile. This metabolic reprogramming may be the central hub that enables and sustains its cytotoxic and secretory functions. * **Surprising Findings:** The most specific genetic markers for this cell are not classic immune-related genes like cytokine receptors or transcription factors, but rather core components of the mitochondrial respiratory chain. Furthermore, the low specificity score of [IFNG](/details-gene/3458), a known product of this cell, is highly counterintuitive and underscores that its function, while important, is not unique to this cell type within a broader activated immune landscape. * **Testable Questions:** Does selective inhibition of mitochondrial ATP synthesis (e.g., with oligomycin) disproportionately impair the perforin-mediated killing capacity of [activated type II NK T cells](/details-cell/CL0000931) when compared to other effector cells like conventional [CD8-positive, alpha-beta T cells](/details-cell/CL0000625)? 2. **Hypothesis: Activated Type II NK T cells utilize a sophisticated post-transcriptional regulatory network to precisely control the timing and intensity of their immune response.** The high specificity of RNA-binding proteins such as [ZFP36](/details-gene/7538) and splicing factors like [DDX5](/details-gene/1655) suggests that the cell's activated state is maintained through active management of its transcriptome. This allows for rapid but controlled deployment of inflammatory mediators, preventing immunopathology. * **Surprising Findings:** It is unexpected that generalist RNA regulatory proteins serve as such highly specific markers for a distinct lymphocyte state. This finding implies that the *manner* in which gene expression is regulated is a more defining characteristic of this cell's activation program than the mere presence of a unique set of effector gene transcripts. * **Testable Questions:** If [ZFP36](/details-gene/7538) is knocked out in Type II NK T cells using a CRISPR-Cas9 system, will their activation lead to an uncontrolled, hyper-inflammatory state characterized by significantly prolonged and elevated levels of cytokine mRNA (e.g., for TNF-alpha and IL-2) and subsequent protein secretion?